相关实验视频
Updated: May 22, 2025

12:23
Granulocyte-dependent Autoantibody-induced Skin Blistering
Published on: October 12, 2012
10.4K
由免疫检查点抑制剂camrelizumab引起的牛皮炎:一个病例报告
Yuan-Jing Jiang1, Lu Wu1, Xiao Yang1
1Cancer Center, Daping Hospital, Army Medical University, Chongqing 400042, China.
World journal of clinical cases
|March 17, 2025
概括
像camrelizumab这样的免疫检查点抑制剂可以引起严重的皮肤反应. 早期诊断和多学科管理,包括葡萄糖皮质激素,对于有效治疗这些与免疫相关的不良事件至关重要.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 皮肤病学 皮肤病学
背景情况:
- 免疫疗法,特别是免疫检查点抑制剂 (ICI),如卡梅利马布 (抗PD-1),是癌症治疗的关键方法.
- ICI恢复T细胞活性,但可能导致类似于自身免疫疾病的免疫相关不良事件 (irAEs).
- 由于越来越多地使用ICI,管理iRE至关重要.
研究的目的:
- 报告3级牛皮性皮炎病例,这是一个罕见的免疫相关的皮肤不良事件,在卡梅利祖马布治疗后.
- 突出多学科管理与PD-1抑制剂相关的严重irAEs的重要性.
主要方法:
- 一名67岁的患有食道状细胞癌的男性接受了camrelizumab维护单疗法.
- 患者在开始第四轮治疗后15天就出现了3级牛皮性皮肤炎.
- 管理包括皮肤病学和药房咨询,葡萄糖皮质激素治疗,局部治疗和支持性护理.
主要成果:
- 患者出现了严重的免疫检查点抑制剂相关的皮疹.
- 随着适当的治疗,症状在出院后15天内消失,导致卡梅利祖马布的停用.
- 这个案例说明了一个严重的,但可以管理的,与免疫相关的皮肤不良事件.
结论:
- 越来越多地使用ICI需要意识到潜在的安全问题,特别是irAEs.
- 早期识别,准确的诊断和迅速的多学科管理对于解决严重的IRE至关重要.
- 这一案例强调了需要对接受PD-1抑制剂的患者进行警监测和专门的皮肤病治疗的必要性.
相关概念视频
Skin Diseases and Disorders
2.8K
Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
2.8K
Skin Cancer
3.0K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
3.0K
Immunodeficiency Diseases
884
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
There are three main causes of immunodeficiency...
884
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
107
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
107
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
126
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
126
Tumor Immunotherapy
457
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
457

